| Ytd | -1.70% | |
| 1y | 1630.55% |
| Open | 137.18 | Prev Close | 133.26 | Low | 131.86 | High | 139.35 | Mkt Cap | 10.57B |
| Vol | 4.48M | Avg Vol | 1.96M | EPS | -5.25 | P/E | N/A | Forward P/E | -40.56 |
| Beta | -0.20 | Short Ratio | 1.70 | Inst. Own | 70.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-23 | 50-d Avg | 111.67 | 200-d Avg | 111.73 | 1yr Est | 150.73 |
Surgepays Inc (NASDAQ: SURG) rose in pre-market trading after amending agreement with wireless netwo
Shares rose 5% after the biotech moved to bolster its balance sheet through an upsized stock offerin
Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross P
Abivax SA raised $800 million in an expanded share sale on Wednesday after strong investor demand,
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Citizens analyst Jason N. Butler reiterates Abivax (NASDAQ:ABVX) with a Market Outperform and mai
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of Ameri
Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 1,
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Dep
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Dep
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July
Abivax Announces Launch of Public Offering of American Depositary Shares PARIS, France – June 30, 20
Jefferies analyst Faisal Khurshid upgrades Abivax (NASDAQ:ABVX) from Hold to Buy and raises the p
Abivax SA (NASDAQ:ABVX, EPA:ABVX, FRA:2X10, FRA:2X1) shares surged more than 40% on Tuesday after th
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
US stocks traded higher, Nasdaq up 150 points. Dow up 0.02%, Nasdaq up 0.68%, S&P 500 up 0.28%.
Leerink Partners analyst Thomas Smith maintains Abivax (NASDAQ:ABVX) with a Outperform and raises
Stocks up, Dow Jones +100 points. AEVEX Corp shares rose 11.8% on $50m Air Force contract. Other big
Abivax SA (NASDAQ:ABVX, EPA:ABVX, FRA:2X10, FRA:2X1) shares surged more than 40% on Tuesday after th
Abivax (ABVX) stock skyrockets 36% following strong Phase 3 maintenance data for its ulcerative coli
Wedbush analyst David Nierengarten maintains Abivax (NASDAQ:ABVX) with a Neutral and raises the p
Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s
BTIG analyst Julian Harrison maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price targe
AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful C
The late-stage clinical trial data of the medicine, released late on Monday, showed that malignancie
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Saf
Abivax said on Monday its experimental ulcerative colitis drug helped harder-to-treat groups of pati
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful C
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Abivax's Phase 3 ulcerative colitis data met remission goals, but cancer cases in the study rais
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
Wall Street analysts upgraded top names like HPE, AESI, MAC, ABVX and more, while revising their pri
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock
Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and lowers the
Jefferies analyst Faisal Khurshid downgrades Abivax (NASDAQ:ABVX) from Buy to Hold and lowers the
Morgan Stanley analyst Judah Frommer maintains Abivax (NASDAQ:ABVX) with a Overweight and lowers
Wedbush analyst David Nierengarten upgrades Abivax (NASDAQ:ABVX) from Underperform to Neutral and
Citizens analyst Jason N. Butler maintains Abivax (NASDAQ:ABVX) with a Market Outperform and rais
Abivax shares plunge more than 35% as cancer cases reported in a Phase 3 trial overshadow strong eff
HPE: 30% | Hewlett Packard Enterprise shares are trading higher after the company reported better-th
HPE stock jumps 26.55% after reporting strong revenue growth. Top gainers are DXST, MRVL and more. T
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderate
Citizens analyst Jason N. Butler reiterates Abivax (NASDAQ:ABVX) with a Market Outperform and mai